| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.26 | 8e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.22 | 9e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.23 | 0.0001 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.24 | 0.0001 |